Place of Bemiparin in Clinical Practice

Ye.I. Kinoshenko, V.V. Nikonov

Abstract


In the article the authors paid attention to the use of heparin in clinical practice. Data from clinical trials on the efficacy of second-generation low-molecular weight heparin, bemiparin sodium (Zibor®), for the treatment and prevention of venous thromboembolic events in various categories of patients are provided.

Keywords


venous thromboembolism; low-molecular weight heparin; bemiparin; clinical studies

References


Бокарев И.Н., Попова Л.В., Кондратьев Т.Б. Венозный тромбоэмболизм: лечение и профилактика // Cons. Med. Хирургия. — 2005. — 7. — 1.

Hidalgo M. Prophylaxis of venous thromboembolism in abdominal wall surgery // Hernia. — 2000. — 4. — 242-7.

Llau J.V. Anesthesia and surgical prophylaxis of VTE // Program Review of the Venous Thromboembolic Disease. — 2007. — Р. 212-34.

Загородний H.B. Профилактика тромбоэмболических ­осложнений у ортопедических больных при эндопротезировании крупных суставов // Материалы городского симпозиума «Профилактика тромбоэмболических осложнений в травматологии и ортопедии». — М., 2003. — С. 34.

Kim V., Spandorfer J. Epidemiology of venous thromboembolic disease // Emerg. Med. Clin. North Amer. — 2001. — 19 (4). — 839-59.

Дзяк Г.В., Клигуненко E.H., Снисарь В.И. Фракционированные и нефракционированные гепарины в интенсивной терапии. — М.: Медпресс-информ, 2005.

Кондратьева Т.Б., Макаров В.А. Применение гепаринов в клинической практике // Интернет-сайт InteLabs: Рус. мед. журн. — 2006–2007.

Яковлев В.В. Тромбоэмболия легочной артерии. Диагностика, лечение, профилактика // Рус. мед. журн. — 1998. — 6 (16).

Geerts W.H. et al. Prevention of venous thromboembolism // J. Chest. — 2004. — 126. — 338S-400S.

Kakkar W. et al. A comparative double-blind, randomized trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group // Tromb. Haemost. — 2000. — 83 (4). — 523-9.

Navarro-Quilis A. et al. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial // J. Thromb. Haemost. — 2003. — 1. — 425-32.

Planes A. Review on bemiparin sodium — a new second generation low-molecular-weight heparin-and its applications in venous thromboembolism // Exp. Opin. Pharmacother. — 2003. — 4. — 1551-61.

Gonzalez M.J. Clinical experience with bemiparin and new reseach lines // Program Review of the Venous Thromboembolic Disease. — 2007. — Р. 262-341.

Honorato J. el al. Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery // Pharmacoeconomics. — 2004. — 22 (13). — 885-94.

Futterman L., Lemberg L. A silent killer-oftenpreventable // Amer. J. Crit. Care. — 2004. — 13 (5). — 431-6.

Bergqvist D. et al. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis // Br. J. Surg. — 1986. — 73 (3). — 204-8.

Lassen M.R., Borris L.C., Nacov R.L. Use of the low molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization // N. Engl. J. Med. — 2002. — 347. — 726-30.

Oger E. Incidence of venous thromboembolism: a community-based stady in western France // J. Thromb. Haemost. — 2000. — 83. — 657-60.

White R.H. et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 // J. Thromb. Haemost. — 2005. — 93. — 298-305.




DOI: https://doi.org/10.22141/2224-0586.6.53.2013.88700

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта